The U.S. Food and Drug Administration today approved the vaccine Gardasil MRK for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus types 6, 11, 16, and 18 in people ages 9 through 26 years.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
